A novel EGFR mutation in exon 18 with high sensitivity to EGFR TKI treatment with reduced dose.
Erika P
EP
Brandão
Marcos Gustavo
MG
Pantarotto
Marcelo
M
Cruz
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D020125:Mutation, Missense / Q000235:genetics*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors